CaliPharms Inc is a developmental stage acquisition company. The Company is focused on acquiring, merging, and joint venturing with legally permitted fully operational marijuana-cannabis businesses. The Company is seeking acquisitions in medical marijuana-cannabis cultivation. The Company focuses on the medical-grade marijuana-cannabis within the State of California. The Company is also expanding into other sectors that support the legalized marijuana industry.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
29/07/26	$0.000001	-.--%	1,998,000

Delayed Quote OTC Markets

More quotes

Market Closed - OTC Markets Other stock markets 17:30:00 29/07/2026 +04			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-

13/11/18	CaliPharms, Inc. Launches a New CBD Muscle & Joint Relief Roll On Gel	CI
30/08/18	Joe Pavlik Joins the Advisory Board of CaliPharms, Inc	CI

Market Cap	401K 349K 325K 298K 563K 38.31M 572K 3.83M 1.5M 19.07M 1.51M 1.47M 63.95M	P/E 2012 *	-	P/E 2013	-0.51x
Enterprise Value	1.07M 928K 864K 793K 1.5M 102M 1.52M 10.19M 4M 50.75M 4.01M 3.92M 170M	EV / Sales 2012 *	-	EV / Sales 2013	-
Free-Float	100%	Yield 2012 *	-	Yield 2013	-

13/11/18	CaliPharms, Inc. Launches a New CBD Muscle & Joint Relief Roll On Gel	CI
30/08/18	Joe Pavlik Joins the Advisory Board of CaliPharms, Inc	CI
14/08/18	Calipharms Announces Beverage Master Distributor Agreement with One Elite Sports	CI
11/01/18	CaliPharms Mulls Acquisitions	CI
26/12/17	Bayport International Holdings, Inc. Engages CaliPharms, Inc. to Expand CBD Product Offering for Weedwiser e-commerce Platform	CI
13/07/17	CaliPharms Mulls Acquisitions	CI
17/04/17	CaliPharms Enters Acquisition Discussions With United Cannabis	CI
28/03/17	CaliPharms, Inc. completed the acquisition of 51% stake in Pacific Cannabis Growers, Inc.	CI
16/03/17	CaliPharms, Inc. signed a non-binding term sheet to acquire 51% stake in Pacific Cannabis Growers, Inc.	CI
07/02/17	Kleangas Energy Technologies, Inc. completed the acquisition of 51% stake in Country Junction Farms.	CI
10/01/17	Kleangas Energy Technologies, Inc. signed a terms sheet to acquire Country Junction Farms for $3.4 million.	CI
26/12/16	Kleangas Energy Seeks Acquisitions	CI
22/07/15	Kleangas Energy Technologies, Inc cancelled the acquisition of Company, Inc. (“CI”) from Jerry Hansen, Tracy Johnson and The PI Foundation.	CI

15/11/18	CaliPharms Debuts New CBD Muscle & Joint Relief Product at Marijuana Business Conference in Las Vegas	GL
19/09/18	CaliPharms has Embarked on the Research and Development of its Initial Series of Naturally Derived CBD (Cannabidiol) Products	GL
30/08/18	Celebrity Fitness Expert & Formulator Joe Pavlik Joins the CaliPharms Advisory Board	GL
23/08/18	CaliPharms Enters Discussions With THC Beverage Company and CBD Producer	GL
14/08/18	CaliPharms And Beverage Master Distributor Sign LOI	GL

CaliPharms, Inc. Stock

Stocks

KGET

US4984561021

Pharmaceuticals

Valuation: CaliPharms, Inc.

Latest news : CaliPharms, Inc.

Press Releases: CaliPharms, Inc.

Course Extremes

Alternative Medicine

Financials

Company Profile

Quotes

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CALIPHARMS, INC.	-.--%	-.--%	-	-	13.88K
YUNNAN BAIYAO GROUP CO.,LTD	+0.21%	+3.65%	-6.09%	-0.23%	13.96B
BEIJING TONGRENTANG CO., LTD	+0.15%	+5.03%	-28.44%	-47.91%	5.34B
DONG-E-E-JIAO CO., LTD.	-1.12%	+7.35%	+5.65%	+10.86%	5.16B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	+1.56%	+2.99%	+3.30%	-29.48%	4.18B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.03%	+4.59%	-1.21%	+1.24%	3.79B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	-0.33%	+0.68%	-0.85%	+7.92%	3.66B
TASLY PHARMACEUTICAL GROUP CO., LTD	+1.51%	+2.28%	-3.24%	+18.97%	3.57B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+0.90%	+2.07%	-14.25%	-21.00%	2.46B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	-2.04%	+4.97%	-1.96%	+54.36%	1.92B
Average	+0.08%	+1.97%	-5.23%	-0.59%	4.4B
Weighted average by Cap.	+0.16%	+2.68%	-5.73%	-3.91%

	2012	2013
Net sales	-	-
Net income	-917K -797K -742K -681K -1.29M -87.53M -1.31M -8.74M -3.43M -43.57M -3.44M -3.37M -146M	-216K -188K -175K -161K -304K -20.66M -308K -2.06M -810K -10.29M -813K -795K -34.5M
Net Debt	617K 536K 499K 458K 865K 58.87M 879K 5.88M 2.31M 29.31M 2.32M 2.27M 98.27M	667K 580K 539K 495K 935K 63.64M 950K 6.36M 2.5M 31.68M 2.5M 2.45M 106M

1 year	0		0
3 years	0		0
5 years	0		0
10 years	0		0.01